Related Experiment Video

Updated: May 22, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma

Ji-Sheng Li1, Jian-Ming Ying, Xiu-Wen Wang

  • 1Department of Chemotherapy, Shandong University, Jinan, Shandong, People's Republic of China.

Chinese Journal of Cancer
|May 11, 2012
PubMed

Insights

Epigenetic silencing of tumor suppressor genes (TSGs) drives esophageal squamous cell carcinoma (ESCC). Aberrant promoter methylation of TSGs offers potential biomarkers for early detection and prognosis in ESCC patients.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Esophageal squamous cell carcinoma (ESCC) is a significant cause of cancer mortality, particularly in Asia.
  • Epigenetic alterations, specifically promoter methylation, play a crucial role in the silencing of tumor suppressor genes (TSGs) during ESCC development.
  • Identifying these epigenetically silenced TSGs is vital for understanding ESCC pathogenesis.

Purpose of the Study:

  • To review recent findings on aberrant promoter methylation of TSGs in ESCC.
  • To elucidate the role of disrupted epigenetic regulation in ESCC tumorigenesis.
  • To highlight the potential of these TSGs as diagnostic and prognostic biomarkers.

Main Methods:

  • Literature review of recent studies on epigenetic modifications in ESCC.
  • Analysis of identified TSGs silenced by promoter methylation.
  • Evaluation of the clinical relevance of these epigenetic markers.

Main Results:

  • Numerous novel TSGs have been identified as epigenetically silenced in ESCC through promoter methylation.
  • Aberrant methylation patterns of these TSGs are associated with ESCC initiation and progression.
  • These methylated TSGs show promise as biomarkers for risk stratification, early diagnosis, and predicting outcomes.

Conclusions:

  • Disrupted epigenetic regulation via promoter methylation of TSGs is a key mechanism in ESCC.
  • Epigenetically silenced TSGs represent valuable biomarkers for improving ESCC management.
  • Further research into these biomarkers can enhance early detection and patient prognosis.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...